Abstract
Objective: The aim of this study was to evaluate whether the change in the mode of supply of HIV medicines to a homecare model was associated with any change in adherence and patient outcomes.
Method: Retrospective analysis of medical records of 100 patients who received supplies from a clinic-based hospital HIV pharmacy (UC) and 100 patients who were started on home delivery over a three-month period were followed up over six months. Data on patient demographics, type of HIV drug regimen, HIV viral load, CD4% and adherence status were analysed.
Results: The mode of delivery had no significant effect on CD4% (p > 0.05), HIV viral load status (p > 0.05) or adherence status (p > 0.05). There was a significant increase in CD4% over time for both groups (p < 0.01).
Conclusion: This study indicates that expanding home delivery as a model of care in London HIV clinics is safe and does not affect adherence and patient outcomes as indicated by HIV viral load and CD4%.
Method: Retrospective analysis of medical records of 100 patients who received supplies from a clinic-based hospital HIV pharmacy (UC) and 100 patients who were started on home delivery over a three-month period were followed up over six months. Data on patient demographics, type of HIV drug regimen, HIV viral load, CD4% and adherence status were analysed.
Results: The mode of delivery had no significant effect on CD4% (p > 0.05), HIV viral load status (p > 0.05) or adherence status (p > 0.05). There was a significant increase in CD4% over time for both groups (p < 0.01).
Conclusion: This study indicates that expanding home delivery as a model of care in London HIV clinics is safe and does not affect adherence and patient outcomes as indicated by HIV viral load and CD4%.
| Original language | English |
|---|---|
| Number of pages | 5 |
| Journal | International Journal of STD & AIDS |
| DOIs | |
| Publication status | E-pub ahead of print - 2014 |
